Inhibitors | Comment | Organism | Structure |
---|---|---|---|
diisopropyl fluorophosphate | inhibits esterase activity | Ovophis okinavensis | |
tosyl-L-lysine chloromethyl ketone | less effective on esterase activity than diisopropyl fluorophospate | Ovophis okinavensis |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
soluble | - |
Ovophis okinavensis | - |
- |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
additional information | - |
amino acid composition | Ovophis okinavensis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Ovophis okinavensis | - |
Himehabu snake | - |
Purification (Comment) | Organism |
---|---|
- |
Ovophis okinavensis |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
venom | - |
Ovophis okinavensis | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
42 equivalent to NIH (National Institute of Health)-units of thrombin | Ovophis okinavensis |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Fibrinogen + H2O | - |
Ovophis okinavensis | Fibrinopeptide A + fibrinopeptide B + ? | - |
? | |
Nalpha-benzoyl-L-Arg 4-nitroanilide + H2O | - |
Ovophis okinavensis | ? | - |
? | |
Tosyl-L-Arg methyl ester + H2O | - |
Ovophis okinavensis | ? | - |
? |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
additional information | - |
pI: 8.2 | Ovophis okinavensis |
8 | - |
- |
Ovophis okinavensis |